Evidence map›Paper›PMID 37950067›Full record

ArticleThe ISME journal2023

Ginsenoside Rg3 enriches SCFA-producing commensal bacteria to confer protection against enteric viral infection via the cGAS-STING-type I IFN axis.

Gan Wang, Jingtianyi Liu, Yanan Zhang, Jinyan Xie, Shuxian Chen, Yuhua Shi, Fushan Shi, Shu Jeffrey Zhu

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Human-Centered Innovation: Precision Nutrition and the Future of Food.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Journal of the Endocrine Society · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Frontiers in microbiology · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gan WangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Jingtianyi LiuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Yanan ZhangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Jinyan XieDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Shuxian ChenDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Yuhua ShiDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Fushan ShiDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.
Shu Jeffrey ZhuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China. shuzhu@zju.edu.cn.ORCID 0000-0003-2919-5473
Zhejiang A & F University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32172864National Natural Science Foundation of China (National Science Foundation of China) U21A20261
6 · The paper itself

Abstract

The microbiota-associated factors that influence host susceptibility and immunity to enteric viral infections remain poorly defined. We identified that the herbal monomer ginsenoside Rg3 (Rg3) can shape the gut microbiota composition, enriching robust short-chain fatty acid (SCFA)-producing Blautia spp. Colonization by representative Blautia coccoides and Blautia obeum could protect germ-free or vancomycin (Van)-treated mice from enteric virus infection, inducing type I interferon (IFN-I) responses in macrophages via the MAVS-IRF3-IFNAR signaling pathway. Application of exogenous SCFAs (acetate/propionate) reproduced the protective effect of Rg3 and Blautia spp. in Van-treated mice, enhancing intracellular Ca

Indexed as

Interferon Type IVirus DiseasesAnimalsFatty Acids, VolatileGinsenosidesImmunity, InnateMembrane ProteinsMiceNucleotidyltransferasesFatty Acids, Volatileginsenoside Rg3GinsenosidesInterferon Type IMembrane ProteinsNucleotidyltransferases

Identifiers

PMID37950067
PMCPMC10689736
OpenAlexW4388567871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.